CTRI/2020/05/024967已完成4 期
A Prospective, Open label, Randomized-controlled study to evaluate the efficacy and safety of MyVir tablets in mildly symptomatic COVID- 19 patients
MiLab LifeSciences P Ltd0 个研究点目标入组 42 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Subjects age group 18 - 65 years both gender
- •2.Patients diagnosed with COVID-19 positive mild symptomatic patients (Confirmed by RTPCR) - Patients with uncomplicated upper respiratory infection
- •a.Spo2 >94% in room air
- •b.Respiratory rate <24 per min
- •c.No evidence of hypoxaemia or breathlessness
- •3.Subjects willing to give a written informed consent and come for a regular follow up
- •4.Subject willing to abide by and comply with the study protocol
排除标准
- •i.Presence of acute hypoxic respiratory failure.
- •ii.Intensive care unit (ICU) stay.
- •iii.Patients who need mechanical ventilation.
- •iv.Category 6 or 5 based on modified 7-category ordinal scale of clinical status.
研究者
相似试验
已完成
不适用
Clinical Study to Evaluate the Benefits of Saffola Oats with Diet & Exercise in Improving Cardiovascular Health of Hyperlipidemic IndividualsCTRI/2010/091/006115Spectrum Clinical Research Pvt Ltd60
已完成
4 期
Clinical trial on Immunity and antiviral for quarantine patients of COVID-19CTRI/2020/06/025527Vopec Pharmaceuticals Pvt Ltd
已完成
3 期
Clinical trial on COVID 19 patients to Improve ImmunityCTRI/2020/08/027041Venkat Pharma
招募中
3 期
Clinical trial on Covid 19 patientsCTRI/2021/04/033188Zum Heilen Diagnostic and Therapeutics Pvt Ltd120
已完成
不适用
A prospective, open label, randomized, controlled trial of tocilizumab versus cyclophosphamide in patients with microscopic polyangiitisMicroscopic polyangiitisJPRN-UMIN000011244Saitama Medical Center, Saitama Medical University Department of Rheumatology and Clinical Immunology40